Insider · CIK 0002156611
Brandon Yaras
Files at ATYR (aTYR PHARMA INC). First filing -, latest -.
In brief
Brandon Yaras files SEC Form 4 as CFO at ATYR (aTYR PHARMA INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brandon Yaras has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ATYR aTYR PHARMA INC | AGrant or award Employee Stock Option (right to buy)derivative | +410,000 | $0.00 | $0 | 410,000 | 13 d ago |
Questions about Brandon Yaras
Answered from the filings on this page, as of the latest one.
Is Brandon Yaras buying or selling?
Brandon Yaras has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brandon Yaras's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brandon Yaras has 0.
Where does Brandon Yaras file Form 4?
Brandon Yaras has filed Form 4 at ATYR (aTYR PHARMA INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.